Combination Immunotherapy Animation
Вставка
- Опубліковано 10 вер 2024
- This mechanism of action (MoA) animation was created for Bristol Myers Squibb to visually convey the science behind their oncology combination treatment, OPDIVO® (nivolumab), and YERVOY® (ipilimumab). This drug combination is indicated for the treatment of advanced melanoma.
OPDIVO® + YERVOY® are two immunotherapies that BMS has combined to harness the body’s immune system to fight cancer. The animation tells the story of the combined medications and how they help the body attack cancer by shrinking tumors.
OPDIVO® is a monoclonal antibody, an anti-PD-1 drug, that promotes the tumor-killing effects of T-cells. YERVOY® is also a monoclonal antibody, an anti-CTLA-4 drug, that helps strengthen the immune system by promoting the function and growth of T-cells. The combination of these antibodies promotes an enhanced anti-tumor response.
This animation is hosted on the OPDIVO® HCP website for healthcare professionals to discover how these drugs work collectively.
In Aug 2023 I was diagnosed with stage 4 stomach cancer and in Oct 2023 started Yervoy + Opdivo treatment and now Aug 2024 CT scan and EGD show no sign of cancer. i did have side effect of now having Hypothyroidism and Adrenal Insufficiency. I had MSI - High and TMB - High.
So far it's working on my wife's sarcoma . 🙏
how is your wife doing?
@irinatelyatinskaya6516 My beautiful wife past away in April of 2023 :(
Excellent explanation
In order for Yervoy and Opdivo to succeed, how important is my microbiome?
How important is fiber intake and how many grams of fiber should be taken on a daily basis for an adult male in order for Yervoy and Opdivo to succeed.
this medicine killed my brother in low
How ???
@@Yashpandey09 He has really bad colliders. After first treatment and after second treatment, they have to cut almost all her intestine.
Four months later he passed away